ad

Is Entero Healthcare Solutions the Best Stock in Its Sector? A Look at the Numbers

Entero Healthcare Solutions CMP Rs 1,847 (25 Sep 2026). Market cap Rs 8,069 Cr. ROE 6.81%. P/E 48.13x versus Industry P/E 38.64x.


25 Sept 2026 • 9:30 am

Is Entero Healthcare Solutions the Best Stock in Its Sector? A Look at the Numbers

Quick Answer

Entero Healthcare Solutions is one of the names investors compare when screening the Healthcare sector, built on a 6.81% return on equity and a P/E of 48.13x against an Industry P/E of 38.64x. Whether Entero Healthcare Solutions is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.

Is Entero Healthcare Solutions the best stock in its sector? The stock trades on the NSE at Rs 1,847 as of 25 September 2026, within its 52-week range of Rs 944.00 to Rs 1,920.00. Entero Healthcare Solutions Ltd distributes pharmaceuticals and healthcare products through a technology-enabled distribution network.

Entero Healthcare Solutions sits in the Healthcare sector, and its 6.81% ROE and 48.13x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector's Industry P/E benchmark.

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers

Click Here – Get Free Investment Predictions

About Entero Healthcare Solutions

Entero Healthcare Solutions Ltd distributes pharmaceuticals and healthcare products through a technology-enabled distribution network. It distributes pharmaceuticals and healthcare products through a technology-enabled distribution network, and the stock is trading near its 52-week high. At a market capitalisation of Rs 8,069 Cr, it is tracked as part of the Healthcare sector on Univest.

Is Entero Healthcare Solutions the Best Stock in Its Sector?

Entero Healthcare Solutions makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, combining a 6.81% ROE with a 48.13x P/E against the sector's 38.64x Industry P/E. Entero Healthcare Solutions' 48.13x P/E is above the 38.64x Industry P/E, a premium built on its technology-enabled distribution model, though its 6.81% ROE is modest relative to the multiple, and the stock is near its 52-week high.

Metric Entero Healthcare Solutions
CMP (NSE) Rs 1,846.80
52-Week High / Low Rs 1,920.00 / Rs 944.00
Market Cap Rs 8,069 Cr
P/E (TTM) vs Industry P/E 48.13x vs 38.64x
P/B 4.80
ROE 6.81%
EPS (TTM) Rs 38.52
Dividend Yield 0.00%
Debt to Equity 0.40

Compare Entero Healthcare Solutions Against Other Healthcare Sector Stocks

How Entero Healthcare Solutions Compares Against Its Healthcare Sector Peers

The table below sets Entero Healthcare Solutions against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.

Company Market Cap (Rs Cr) P/E ROE Debt to Equity
Entero Healthcare Solutions 8,069 48.13 6.81% 0.40
CORONA Remedies 13,237 66.51 24.79% 0.22
Dr. Agarwal's Health Care 15,908 85.92 6.58% 0.53
Peer average (2 companies) - 76.22 15.68% 0.38

Against this peer set, Entero Healthcare Solutions's 6.81% ROE is below the 15.68% peer average, and its P/E of 48.13x runs below the peer average of 76.22x. Entero Healthcare Solutions' 48.13x P/E is above the 38.64x Industry P/E, a premium built on its technology-enabled distribution model, though its 6.81% ROE is modest relative to the multiple, and the stock is near its 52-week high.

What Makes Entero Healthcare Solutions Worth Watching in Healthcare

  • Technology-enabled distribution network: Operating a technology-enabled pharmaceutical distribution network gives Entero Healthcare Solutions scale and efficiency advantages over traditional distributors.
  • Moderate leverage: A debt to equity ratio of 0.40 is manageable for a healthcare distribution business.
  • Trading near its 52-week high: The stock has rallied sharply and is currently trading close to its 52-week high.

Entero Healthcare Solutions Valuation: Is It Justified?

Entero Healthcare Solutions' 48.13x P/E is above the 38.64x Industry P/E, a premium built on its technology-enabled distribution model, though its 6.81% ROE is modest relative to the multiple, and the stock is near its 52-week high. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.

Also read – Is Electronics Mart India the Best Stock in Its Sector? A Look at the Numbers

Download the Univest iOS App or Univest Android App to track Entero Healthcare Solutions and other Healthcare sector stocks.

How to Track Entero Healthcare Solutions Before You Invest

Before deciding whether Entero Healthcare Solutions deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.

  1. Open the Univest Screener and search for Entero Healthcare Solutions to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
  2. Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
  3. Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
  4. Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.

Conclusion

Entero Healthcare Solutions earns a place in the best stock in its sector conversation on the strength of a 6.81% ROE and a P/E of 48.13x against a 38.64x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Is Entero Healthcare Solutions the best stock in its sector?

Ans. Entero Healthcare Solutions has a 6.81% ROE and trades at 48.13x P/E against a 38.64x Industry P/E, and compares below the peer average ROE of 15.68% in this article's named comparison, so the answer depends on what an investor is prioritising.

What is the current share price of Entero Healthcare Solutions?

Ans. Entero Healthcare Solutions was trading at Rs 1,846.80 on the NSE as of 25 September 2026, within its 52-week range of Rs 944.00 to Rs 1,920.00.

What sector does Entero Healthcare Solutions belong to?

Ans. Entero Healthcare Solutions is classified under the Healthcare sector on Univest.

How does Entero Healthcare Solutions compare to its sector peers on P/E?

Ans. Entero Healthcare Solutions's P/E of 48.13x is below the 76.22x average of the 2 named peers compared in this article.

What is Entero Healthcare Solutions's return on equity?

Ans. Entero Healthcare Solutions reported a return on equity of 6.81%, which is below the 15.68% average of its named peers in this comparison.

Should I invest in Entero Healthcare Solutions based on its sector position?

Ans. Entero Healthcare Solutions's sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down